Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Recs

2
Player Avatar TMFBreakerBrian (99.71) Submitted: 6/10/2008 3:33:40 PM : Underperform Start Price: $3.73 SVA Score: +4.35

Any company garnering a positive rating from Dutton Associates should set off all sorts of warning bells to investors.

Member Avatar zygnoda (27.08) Submitted: 6/17/2008 10:12:17 PM
Recs: 1

Dirty dutton..

Featured Broker Partners


Advertisement